Reach Us +44-1522-440391
Influence Of Age On Recombinant Human Erythropoietin (rHuEPO) Responsiveness In Hemodialysis Patients With And Without Diabetes | 9167
ISSN: 2161-0959

Journal of Nephrology & Therapeutics
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Influence of age on recombinant Human Erythropoietin (rHuEPO) responsiveness in hemodialysis patients with and without diabetes

2nd International Conference on Nephrology & Therapeutics

Zorica Dimitrijevic, Karolina Paunovic, Branka Mitic, Stanimir Ljubenovic, Goran Paunovic and Jelena Kostic

Posters: J Nephrol Therapeutic

DOI: 10.4172/2161-0959.S1.010

Aim: The aim of the study was to determine if there is a relationship between age and rHuEPO requirement in maintenance hemodialysis patients (HD), and if this association is maintained in diabetics. Patients and Methods: A retrospective analysis of maintenance HD patients was performed. Exclusion criteria included duration of HD less than 3 months, active infection, evidence of active blood loss, and/or recent hospitalization. Patients were divided into 2 groups by diabetic status. Results: One hundred eighty-nine patients were included. Diabetics (n=45) were found to be older (62?12 yrs vs. 52?17 yrs; p=0.008) and used less rHuEPO (98.35?14.48 IU /kg TT/weekly vs. 73.30?10.55 IU/kg TT/weekly, p=0.005) when compared to non-diabetics. There was no statistical difference in iron saturation, ferritin, hemoglobin levels, and markers of malnutrition- inflammation. When the 2 groups were analyzed independently, a significant negative correlation of rHuEPO usage and age was found (r=-0.269; p=0.037) in non-diabetics. However, this relationship was not maintained in the diabetic group. Conclusion: This data suggest that there is a decreased rHuEPO requirement in diabetics as compared to non-diabetics. In addition, age may enhance rHuEPO responsiveness in non-diabetics but does not have any influence in diabetics. Finally, the improved response in diabetics may not be due to the difference in age, but may be due to other etiologies. Anemia management needs to be individualized among diabetics and non-diabetics due to the varying rHuEPO responsiveness.
Zorica Dimitrijevic has completed her M.D. and Ph.D. from University of Nis, Serbia and works as a staff physician at Clinic of Nephrology as well as teaching assistant in nephrology at Medical school, University of Nis, Serbia. She has published number of papers in reputed medical journals